Clinical Trials Browser

Active not recruiting × Interventional × Eflornithine × Clear all

NCT03794349 2026-02-18

Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma

Phase 2 Active not recruiting

94 enrolled 14 charts

Neuroblastoma

NCT01349881 2025-03-30

PACES

Phase 3 Active not recruiting

Gastrointestinal

Colorectal Neoplasms